Ticker

Analyst Price Targets — DH

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
August 12, 2026 12:46 pmGeorge HillDeutsche Bank$1.00$0.65TheFly Definitive Healthcare price target lowered to $1 from $3 at Deutsche Bank
August 11, 2026 11:09 amCraig HettenbachMorgan Stanley$1.50$0.70TheFly Definitive Healthcare price target lowered to $1.50 from $2.50 at Morgan Stanley
May 8, 2026 1:14 pmRobert W. Baird$1.10$0.94TheFly Definitive Healthcare price target lowered to $1.10 from $1.30 at Baird
December 18, 2025 12:52 pmCraig HettenbachMorgan Stanley$3.50$2.28TheFly Definitive Healthcare price target lowered to $3.50 from $5 at Morgan Stanley
December 8, 2025 9:13 pmBarclays$2.75$2.45TheFly Definitive Healthcare price target lowered to $2.75 from $3 at Barclays
August 8, 2025 2:15 pmJoe VruwinkRobert W. Baird$4.00$3.86TheFly Definitive Healthcare price target raised to $4 from $3 at Baird
September 17, 2024 5:33 amDavid LarsenBTIG$7.00$4.44TheFly Definitive Healthcare initiated with a Buy at BTIG
August 9, 2024 9:46 amGeorge HillDeutsche Bank$5.00$3.87TheFly Definitive Healthcare price target lowered to $5 from $7 at Deutsche Bank
August 7, 2024 5:23 amSaket KaliaBarclays$4.00$3.65TheFly Definitive Healthcare price target lowered to $4 from $6 at Barclays
August 6, 2024 9:17 amCraig HettenbachMorgan Stanley$5.00$3.72TheFly Definitive Healthcare price target lowered to $5 from $9 at Morgan Stanley

Latest News for DH

Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International

FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- The special committee (the “Special Committee”) of the Board of Directors of Definitive Healthcare Corp. (the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it has received a non-binding indication of interest (the “Proposal”), dated as of September 1, 2026, from Advent International, L.P., on behalf of…

GlobeNewsWire • Sep 2, 2026
Definitive Healthcare Appoints Clay Ritchey as CEO

FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Board of Directors has appointed Clay Ritchey as the Company's next Chief Executive Officer and as a member of the Board of Directors, each effective September 8, 2026.

GlobeNewsWire • Sep 2, 2026
Definitive Healthcare (NASDAQ:DH) & Certara (NASDAQ:CERT) Financial Comparison

Definitive Healthcare (NASDAQ: DH - Get Free Report) and Certara (NASDAQ: CERT - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, institutional ownership and valuation. Insider and Institutional Ownership 98.7% of Definitive Healthcare

Defense World • Sep 2, 2026
Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of “Reduce” by Analysts

Definitive Healthcare Corp. (NASDAQ: DH - Get Free Report) has received a consensus rating of "Reduce" from the nine analysts that are covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and one has assigned a strong buy recommendation to the company.

Defense World • Aug 21, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for DH.

No House trades found for DH.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top